Bayer maintains its growth momentum

Bayer says it achieved its targets for 2012. Speaking at a media briefing in Leverkusen on 28 February, Marijn Dekkers, CEO, said that all of Bayer’s subgroups—Bayer HealthCare, Bayer CropScience, and Bayer MaterialScience—“posted gains in sales and earnings before special items.” The life-science businesses, comprising HealthCare and CropScience, registered particularly rapid growth and were strengthened by further progress in their innovation pipelines. The company expects “to continue our record development in 2013 and...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers